본문 바로가기
KERD
논문KCI 등재

Vitamin D Deficiency and Comorbidities as Risk Factors of COVID-19 Infection: A Systematic Review and Meta-analysis

Ram Bajpai|Pinki Mishra|Rizwana Parveen|Nidhi Agarwal
대한예방의학회 (The Korean Society For Preventive Medicine)|2022.07|예방의학회지 (Journal of Preventive Medicine and Public Health)|제55권 제4호|pp. 321-333

4

조회

0

다운로드

0

인용

0

참고문헌

키워드

COVID-19Meta-analysisVitamin DRisk factorsComorbidities
주제분류예방의학/직업환경의학

초록

Objectives: Extensive evidence links low vitamin D status and comorbidities with coronavirus disease 2019 (COVID-19) outcomes, but the results of published studies are contradictory. Therefore, we investigated the association of lower levels of vitamin D and comorbidities with the risk of COVID-19 infection. Methods: We searched MEDLINE (via PubMed), Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov for articles published until August 20, 2021. Sixteen eligible studies were identified (386 631 patients, of whom 181 114 were male). We included observational cohort and case-control studies that evaluated serum levels of vitamin D in COVID-19-positive and COVID-19-negative patients. Mean differences (MDs) with 95% confidence intervals (CIs) were calculated. Results: Significantly lower vitamin D levels were found in COVID-19-positive patients (MD, -1.70; 95% CI, -2.74 to -0.66; p=0.001), but with variation by study design (case-control: -4.04; 95% CI, -5.98 to -2.10; p<0.001; cohort: -0.39; 95% CI, -1.62 to 0.84; p=0.538). This relationship was more prominent in female patients (MD, -2.18; 95% CI, -4.08 to -0.28; p=0.024) than in male patients (MD, -1.74; 95% CI, -3.79 to 0.31; p=0.096). Male patients showed higher odds of having low vitamin D levels (odds ratio [OR], 2.09; 95% CI, 1.38 to 3.17; p<0.001) than female patients (OR, 1.17; 95% CI, 0.74 to 1.86; p=0.477). Comorbidities showed inconsistent, but generally non-significant, associations with COVID-19 infection. Conclusions: Low serum vitamin-D levels were significantly associated with the risk of COVID-19 infection. This relationship was stronger in female than in male COVID-19 patients. Limited evidence was found for the relationships between comorbidities and COVID-19 infection, warranting large population-based studies to clarify these associations.

Abstract

Objectives: Extensive evidence links low vitamin D status and comorbidities with coronavirus disease 2019 (COVID-19) outcomes, but the results of published studies are contradictory. Therefore, we investigated the association of lower levels of vitamin D and comorbidities with the risk of COVID-19 infection. Methods: We searched MEDLINE (via PubMed), Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov for articles published until August 20, 2021. Sixteen eligible studies were identified (386 631 patients, of whom 181 114 were male). We included observational cohort and case-control studies that evaluated serum levels of vitamin D in COVID-19-positive and COVID-19-negative patients. Mean differences (MDs) with 95% confidence intervals (CIs) were calculated. Results: Significantly lower vitamin D levels were found in COVID-19-positive patients (MD, -1.70; 95% CI, -2.74 to -0.66; p=0.001), but with variation by study design (case-control: -4.04; 95% CI, -5.98 to -2.10; p<0.001; cohort: -0.39; 95% CI, -1.62 to 0.84; p=0.538). This relationship was more prominent in female patients (MD, -2.18; 95% CI, -4.08 to -0.28; p=0.024) than in male patients (MD, -1.74; 95% CI, -3.79 to 0.31; p=0.096). Male patients showed higher odds of having low vitamin D levels (odds ratio [OR], 2.09; 95% CI, 1.38 to 3.17; p<0.001) than female patients (OR, 1.17; 95% CI, 0.74 to 1.86; p=0.477). Comorbidities showed inconsistent, but generally non-significant, associations with COVID-19 infection. Conclusions: Low serum vitamin-D levels were significantly associated with the risk of COVID-19 infection. This relationship was stronger in female than in male COVID-19 patients. Limited evidence was found for the relationships between comorbidities and COVID-19 infection, warranting large population-based studies to clarify these associations.

참고문헌 (73)

  1. Grant WB, "Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths", Nutrients, 12(4), pp.988~ (2020)
  2. Shah K, "Vitamin D supplementation, COVID-19 and disease severity: a meta-analysis", QJM, 114(3), pp.175~181 (2021)
  3. Ebadi M, "Perspective : improving vitamin D status in the management of COVID-19", Eur J Clin Nutr, 74(6), pp.856~859 (2020)
  4. Wei R, "Mechanisms underlying the regulation of innate and adaptive immunity by vitamin D", Nutrients, 7(10), pp.8251~8560 (2015)
  5. Holick MF, "The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention", Rev Endocr Metab Disord, 18(2), pp.153~165 (2017)
  6. Dankers W, "Vitamin D in autoimmunity : molecular mechanisms and therapeutic potential", Front Immunol, 7, pp.697~ (2017)
  7. Infante M, "Influence of vitamin D on islet autoimmunity and beta-cell function in type 1 diabetes", Nutrients, 11(9), pp.2185~ (2019)
  8. Bouillon R, "Skeletal and extraskeletal actions of vitamin D : current evidence and outstanding questions", Endocr Rev, 40(4), pp.1109~1151 (2019)
  9. Cannell JJ, "Epidemic influenza and vitamin D", Epidemiol Infect, 134(6), pp.1129~1140 (2006)
  10. Cannell JJ, "On the epidemiology of influenza", Virol J, 5, pp.29~ (2008)
  11. Ginde AA, "Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004", Arch Intern Med, 169(6), pp.626~632 (2009)
  12. Gombart AF, "A review of micronutrients and the immune system-working in harmony to reduce the risk of infection", Nutrients, 12(1), pp.236~ (2020)
  13. Wang TT, "Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2", CARD15-defensin beta2 innate immune pathway defective in Crohn disease, 2010, pp.285(4), 2227~2231
  14. D)levels in patients hospitalized with COVID-19 are associated with greater disease severity, "Clin Endocrinol(Oxf)", 2020, 508~511
  15. Berry DJ, "Vitamin D status has a linear association with seasonal infections and lung function in British adults", Br J Nutr, 106(9), pp.1433~1440 (2011)
  16. Kralj M, "Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities-a case report", Clin Case Rep, 9(4), pp.2269~2275 (2021)
  17. Parveen R, "Association of diabetes and hypertension with disease severity in covid-19 patients : a systematic literature review and exploratory meta-analysis", Diabetes Res Clin Pract, 166, pp.108295~ (2020)
  18. Mishra P, "Role of vitamin D in risk reduction of COVID-19: a narrative review", Ann Natl Acad Med Sci(India), 57(1), pp.36~40 (2021)
  19. "Association of vitamin D deficiency and treatment with COVID-19 incidence" (2020)[URL]
  20. D’Avolio A, "25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2", Nutrients, 12(5), pp.1359~ (2020)
  21. Hastie CE, "Vitamin D concentrations and COVID-19 infection in UK Biobank", Diabetes Metab Syndr, 14(4), pp.561~565 (2020)
  22. Zhou YF, "The association between vitamin D deficiency and community-acquired pneumonia: a meta-analysis of observational studies", Medicine(Baltimore), 98(38), pp.e17252~ (2019)
  23. Cutolo M, "Evidences for a protective role of vitamin D in COVID-19", RMD Open, 6(3), pp.e001454~ (2020)
  24. "The possible role of vitamin D in suppressing cytokine storm and associated mortality in COVID-19 patients" (2020)[URL]
  25. "Vitamin D status, body mass index, ethnicity and COVID-19: initial analysis of the first-reported UK Biobank COVID-19 positive cases (n 580) compared with negative controls (n 723)" (2020)[URL]
  26. "Vitamin D deficiency as risk factor for severe COVID-19: a convergence of two pandemics" (2020)[URL]
  27. Ilie PC, "The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality", Aging Clin Exp Res, 32(7), pp.1195~1198 (2020)
  28. "Vitamin D insufficiency is prevalent in severe COVID-19" (2020)[URL]
  29. "Sunlight and vitamin D in the prevention of coronavirus disease (COVID-19) infection and mortality in the United States" (2020)[URL]
  30. Teshome A, "The impact of vitamin D level on COVID-19 infection : systematic review and meta-analysis", Front Public Health, 9, pp.624559~ (2021)
  31. Crafa A, "Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity : a systematic review and meta-analysis", EClinicalMedicine, 37, pp.100967~ (2021)
  32. Page MJ, "The PRISMA 2020 statement : an updated guideline for reporting systematic reviews", BMJ, 372, pp.n71~ (2021)
  33. Stroup DF, "Meta-analysis of observational studies in epidemiology : a proposal for reporting", JAMA, 283(15), pp.2008~2012 (2000)
  34. "Study quality assessment tools"[URL]
  35. Abdollahi A, "The association between the level of serum 25(OH) vitamin D, obesity, and underlying diseases with the risk of developing COVID-19 infection: a case-control study of hospitalized patients in Tehran, Iran", J Med Virol, 93(4), pp.2359~2364 (2021)
  36. Alguwaihes AM, "Severe vitamin D deficiency is not related to SARS-CoV-2 infection but may increase mortality risk in hospitalized adults : a retrospective case-control study in an Arab Gulf country", Aging Clin Exp Res, 33(5), pp.1415~1422 (2021)
  37. Al-Daghri NM, "Vitamin D status of Arab Gulf residents screened for SARS-CoV-2 and its association with COVID-19 infection : a multi-centre case-control study", J Transl Med, 19(1), pp.166~ (2021)
  38. Hernández JL, "Vitamin D status in hospitalized patients with SARS-CoV-2 infection", J Clin Endocrinol Metab, 106(3), pp.e1343~e1353 (2021)
  39. Ferrari D, "Changes in 25-(OH) vitamin D levels during the SARS-CoV-2 outbreak: lockdown-related effects and first-to-second wave difference-an observational study from northern Italy", Biology (Basel), 10(3), pp.237~ (2021)
  40. Li Y, "Assessment of the association of vitamin D level with SARS-CoV-2 seropositivity among working-age adults", JAMA Netw Open, 4(5), pp.e2111634~ (2021)
  41. Sulli A, "Vitamin D and lung outcomes in elderly COVID-19 patients", Nutrients, 13(3), pp.717~ (2021)
  42. Al-Daghri NM, "Vitamin D status correction in Saudi Arabia: an experts’ consensus under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO)", Arch Osteoporos, 12(1), pp.1~ (2017)
  43. Lips P, "Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society", Eur J Endocrinol, 180(4), pp.P23~P54 (2019)
  44. Gaudio A, "Vitamin D levels are reduced at the time of hospital admission in Sicilian SARS-CoV-2-positive patients", Int J Environ Res Public Health, 18(7), pp.3491~ (2021)
  45. Livingston M, "Detectable respiratory SARS-CoV-2 RNA is associated with low vitamin D levels and high social deprivation", Int J Clin Pract, 75(7), pp.e14166~ (2021)
  46. Merzon E, "Low plasma 25(OH)vitamin D level is associated with increased risk of COVID-19 infection : an Israeli population-based study", FEBS J, 287(17), pp.3693~3702 (2020)
  47. "Treatment of vitamin D deficiency in adults" (2020)[URL]
  48. "Cochrane handbook for systematic reviews of interventions" (2011)[URL]
  49. Duval S, "Trim and fill : a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis", Biometrics, 56(2), pp.455~463 (2000)
  50. IntHout J, "Plea for routinely presenting prediction intervals in meta-analysis", BMJ Open, 6(7), pp.e010247~ (2016)
  51. Raisi-Estabragh Z, "Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank", J Public Health (Oxf), 42(3), pp.451~460 (2020)
  52. Raesi A, "Hypocalcemia in Covid-19 : a prognostic marker for severe disease", Iran J Pathol, 16(2), pp.144~153 (2021)
  53. Szarpak L, "A systematic review and meta-analysis of effect of vitamin D levels on the incidence of COVID-19", Cardiol J, 28(5), pp.647~654 (2021)
  54. Bassatne A, "The link between COVID-19 and vItamin D(VIVID) : a systematic review and meta-analysis", Metabolism, 119, pp.154753~ (2021)
  55. Liu N, "Low vitamin D status is associated with coronavirus disease 2019 outcomes : a systematic review and meta-analysis", Int J Infect Dis, 104, pp.58~64 (2021)
  56. Pereira M, "Vitamin D deficiency aggravates COVID-19 : systematic review and meta-analysis", Crit Rev Food Sci Nutr, 62(5), pp.1308~1316 (2022)
  57. Ghasemian R, "The role of vitamin D in the age of COVID-19 : a systematic review and meta-analysis", Int J Clin Pract, 75(11), pp.e14675~ (2021)
  58. Munshi R, "Vitamin D insufficiency as a potential culprit in critical COVID-19 patients", J Med Virol, 93(2), pp.733~740 (2021)
  59. Cai H, "Sex difference and smoking predisposition in patients with COVID-19", Lancet Respir Med, 8(4), pp.e20~ (2020)
  60. Wenham C, "COVID-19: the gendered impacts of the outbreak", Lancet, 395(10227), pp.846~848 (2020)
  61. Muscogiuri G, "Sex differences of vitamin D status across BMI classes : an observational prospective cohort study", Nutrients, 11(12), pp.3034~ (2019)
  62. Sanghera DK, "Vitamin D status, gender differences, and cardiometabolic health disparities", Ann Nutr Metab, 70(2), pp.79~87 (2017)
  63. Pagano MT, "Vitamin D and sex differences in COVID-19", Front Endocrinol(Lausanne), 11, pp.567824~ (2020)
  64. Ye K, "Does serum vitamin D level affect COVID-19 infection and its severity?-A case-control study", J Am Coll Nutr, 40(8), pp.724~731 (2021)
  65. Murdaca G, "Vitamin D and Covid-19 : an update on evidence and potential therapeutic implications", Clin Mol Allergy, 18(1), pp.23~ (2020)
  66. Baktash V, "Vitamin D status and outcomes for hospitalised older patients with COVID-19", Postgrad Med J, 97(1149), pp.442~447 (2021)
  67. Campi I, "Vitamin D and COVID-19 severity and related mortality : a prospective study in Italy", BMC Infect Dis, 21(1), pp.566~ (2021)
  68. Kweder H, "Vitamin D deficiency in elderly : risk factors and drugs impact on vitamin D status", Avicenna J Med, 8(4), pp.139~146 (2018)
  69. Guan WJ, "Comorbidity and its impact on 1590 patients with COVID-19 in China : a nationwide analysis", Eur Respir J, 55(5), pp.2000547~ (2020)
  70. Wang D, "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China", JAMA, 323(11), pp.1061~1069 (2020)
  71. Ho JS, "Obesity in COVID-19 : a systematic review and meta-analysis", Ann Acad Med Singap, 49(12), pp.996~1008 (2020)
  72. Mamelund SE, "The association between socioeconomic status and pandemic influenza : systematic review and meta-analysis", PLoS One, 16(9), pp.e0244346~ (2021)
  73. Yang J, "Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2 : a systematic review and meta-analysis", Int J Infect Dis, 94, pp.91~95 (2020)

관련 논문AI추천

The role of vitamin D deficiency on COVID-19: a systematic review and meta-analysis of observational studiesKaya Mehmet Onur, Pamukçu Esra, Yakar Burkay한국역학회 · Epidemiology and Health2021 · 제43권 Association of vitamin D deficiency with COVID-19 severity and mortality in Iranian people: a prospective observational studyAlireza Fatemi, Ghazaleh Eslamian, Morvarid Noormohammadi, Seyed Hossein Ardehali, Shirin Malek대한중환자의학회 · Acute and Critical Care2021 · 제36권 제4호Serum vitamin D status and metabolic syndrome: a systematic review and dose-response meta-analysis김지혜, Kyueun Lee한국영양학회 · Nutrition Research and Practice2021 · 제15권 제3호비타민 D와 소아 호흡기 감염의 위험성: 무작위 대조 연구에 대한 체계적 문헌고찰 및 메타분석김경효, 안종균, 이도경대한소아감염학회 · Pediatric Infection and Vaccine2016 · 제23권 제2호Circulating 25-hydroxyvitamin D levels and hypertension risk after adjusting for publication bias배종면대한고혈압학회 · Clinical Hypertension2022 · 제28권 Vitamin D status and its association with cardiometabolic risk factors in Korean adults based on a 2008-2010 Korean National Health and Nutrition Examination Survey정지윤, 홍승호한국영양학회 · Nutrition Research and Practice2013 · 제7권 제6호

이 간행물의 다른 논문 (10건)

The KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD): A Korean Chronic Kidney Disease CohortJayoun Kim, Sue K. Park, 오국환, Curie Ahnpp. 313-320Construction of the Mobility to Participation Assessment Scale for Stroke (MPASS) and Testing Its Validity and Reliability in Persons With Stroke in ThailandJiraphat Nawarat, Kanda Chaipinyopp. 334-341Open Communication About Reproductive Health Is Associated With Comprehensive HIV Knowledge and a Non-stigmatising Attitude Among Indonesian Youth: A Cross-sectional StudyPande Putu Januraga, Gede Benny Setia Wirawan, Ni Luh Zallila Gustinapp. 342-360The Busan Regional CardioCerebroVascular Center Project’s Experience Over a Decade in the Treatment of ST-segment Elevation Myocardial InfarctionKyungil Park, Young-Dae Kim, 박태호, 박종성, 김무현, Young-Rak Cho, Kyung Hee Lim, Hyeyeon Moonpp. 351-359Evaluation of the Public Health Emergency Response to the COVID-19 Pandemic in Daegu, Korea During the First Half of 2020Sin Kam, Kyeong Soo Lee, Nam Soo Hong, Tae-Yoon Hwang, Jung Jeung Lee, Hwa-Jin Lee, Keon Yeop Kim, Jong-yeon Kimpp. 360-370
원문 보기